Vancomycin-resistant *Staphylococcus aureus* (VRSA) infection is a serious bacterial infection caused by specific *Staphylococcus aureus* strains that cannot be treated with the antibiotic vancomycin. It primarily affects hospitalized patients, those with chronic health conditions, or individuals with indwelling medical devices. Track Vancomycin resistant Staphylococcus aureus infection activity and outbreaks specific to Delaware.
We're working with Apple to restore our app to the App Store.
Get notified when it's back:
Email [email protected] (subject: REMINDER) or check back in a few days.
*Staphylococcus aureus* resistance to vancomycin was first reported in 2002, following years of increasing vancomycin use. This emergence marked a significant and concerning development in the global fight against antimicrobial resistance, as vancomycin was considered a last-resort antibiotic for MRSA. Its appearance highlighted the urgent need for new antimicrobial agents and stronger infection control practices.
VRSA primarily spreads through direct contact with an infected person's wounds, bodily fluids, or contaminated skin. It can also spread indirectly via contact with contaminated surfaces, objects, or medical equipment. Transmission is most common in healthcare settings where patients may have open wounds, medical devices, or weakened immune systems.
Contagious Period: Varies by disease
Local health department information and state-specific prevention guidance
Our AI-powered surveillance continuously monitors Vancomycin resistant Staphylococcus aureus infection activity across Delaware. We track data from state health departments, local hospitals, CDC reports, and 50+ global health sources to provide early warning of emerging threats.
Get instant push notifications when Vancomycin resistant Staphylococcus aureus infection activity increases in Delaware or your specific county.
For official state health alerts, vaccination locations, and public health guidance specific to Delaware, visit your state health department's website.
Whether you live in Delaware, are traveling there, or have family in the state, understanding Vancomycin resistant Staphylococcus aureus infection prevention is essential. Follow these evidence-based prevention measures:
If you experience symptoms of Vancomycin resistant Staphylococcus aureus infection in Delaware, contact your healthcare provider immediately. Early diagnosis and treatment improve outcomes significantly.
Emergency symptoms: If you experience severe symptoms, difficulty breathing, or signs of dehydration, call 911 or go to your nearest emergency room.
Trusted information from leading health organizations
Official guidance from the U.S. Centers for Disease Control and Prevention
View CDC Resources βGlobal disease surveillance and guidelines from the World Health Organization
View WHO Resources βDisease information on Virus Watcher is reviewed by our Chief Epidemiologist, a former CDC lead analyst for FluSight forecasting. Outbreak data is aggregated from verified sources including BEACON, ProMED, WHO, CDC, and 50+ national health agencies. This information is for educational purposes and should not replace professional medical advice.
Last reviewed: 2026-06-03
Receive instant push notifications when Vancomycin resistant Staphylococcus aureus infection activity increases in Delaware or your travel destinations. Track 200+ diseases with location-based alerts. Used by healthcare systems, EMS, schools, and travelers worldwide.
We're working with Apple to restore our app to the App Store.
Get notified when it's back:
Email [email protected] (subject: REMINDER) or check back in a few days.